GCSF-R expression in myelodysplastic and myeloproliferative disorders and blast dysmaturation in CML

Vidya Sagar Hanumanthu, Samuel Jay Pirruccello

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives: To characterize granulocyte colony-stimulating factor receptor (CD114) expression in normal (n = 20), myelodysplastic (n = 34), and chronic myelogenous leukemia (CML; n = 5) bone marrow by flow cytometry. Methods: Clinical bone marrow samples were analyzed using CD33/CD114/CD34/CD117/CD45. CD114 density (mean fluorescence intensity) and cellular distribution were evaluated on early blasts (CD33-), late blasts (CD33+), promyelocytes, and granulocytes. Results: Normal CD114 acquisition occurred on early blasts, peaked on promyelocytes, and decreased on granulocytes. Forty percent of CD34+ blasts expressed CD114 and one-third were early blasts. In myelodysplastic syndromes, altered CD114 distribution was more informative than density changes. In CML, CD114 density was significantly decreased on early blasts and expression was essentially limited to late blasts. We observed a specific blast dysmaturation pattern in CML involving CD33, CD34, and CD114 that was 83% sensitive and 100% specific in initial diagnosis. Conclusions: CD114 provides useful additional detail in phenotypic assessment of hematopoietic precursor maturation.

Original languageEnglish (US)
Pages (from-to)155-164
Number of pages10
JournalAmerican journal of clinical pathology
Volume140
Issue number2
DOIs
StatePublished - Aug 1 2013

Fingerprint

Granulocyte Precursor Cells
Myeloproliferative Disorders
Granulocytes
Granulocyte Colony-Stimulating Factor Receptors
Bone Marrow
Myelodysplastic Syndromes
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Flow Cytometry
Fluorescence

Keywords

  • CD114
  • Chronic myelogenous leukemia
  • Flow cytometry
  • GCSF-R
  • Myelodysplastic syndrome

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

GCSF-R expression in myelodysplastic and myeloproliferative disorders and blast dysmaturation in CML. / Hanumanthu, Vidya Sagar; Pirruccello, Samuel Jay.

In: American journal of clinical pathology, Vol. 140, No. 2, 01.08.2013, p. 155-164.

Research output: Contribution to journalArticle

@article{f1cf1e64f4da4f9ebe49030f0ffe17f8,
title = "GCSF-R expression in myelodysplastic and myeloproliferative disorders and blast dysmaturation in CML",
abstract = "Objectives: To characterize granulocyte colony-stimulating factor receptor (CD114) expression in normal (n = 20), myelodysplastic (n = 34), and chronic myelogenous leukemia (CML; n = 5) bone marrow by flow cytometry. Methods: Clinical bone marrow samples were analyzed using CD33/CD114/CD34/CD117/CD45. CD114 density (mean fluorescence intensity) and cellular distribution were evaluated on early blasts (CD33-), late blasts (CD33+), promyelocytes, and granulocytes. Results: Normal CD114 acquisition occurred on early blasts, peaked on promyelocytes, and decreased on granulocytes. Forty percent of CD34+ blasts expressed CD114 and one-third were early blasts. In myelodysplastic syndromes, altered CD114 distribution was more informative than density changes. In CML, CD114 density was significantly decreased on early blasts and expression was essentially limited to late blasts. We observed a specific blast dysmaturation pattern in CML involving CD33, CD34, and CD114 that was 83{\%} sensitive and 100{\%} specific in initial diagnosis. Conclusions: CD114 provides useful additional detail in phenotypic assessment of hematopoietic precursor maturation.",
keywords = "CD114, Chronic myelogenous leukemia, Flow cytometry, GCSF-R, Myelodysplastic syndrome",
author = "Hanumanthu, {Vidya Sagar} and Pirruccello, {Samuel Jay}",
year = "2013",
month = "8",
day = "1",
doi = "10.1309/AJCPCLHZR5KUHUBM",
language = "English (US)",
volume = "140",
pages = "155--164",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "2",

}

TY - JOUR

T1 - GCSF-R expression in myelodysplastic and myeloproliferative disorders and blast dysmaturation in CML

AU - Hanumanthu, Vidya Sagar

AU - Pirruccello, Samuel Jay

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Objectives: To characterize granulocyte colony-stimulating factor receptor (CD114) expression in normal (n = 20), myelodysplastic (n = 34), and chronic myelogenous leukemia (CML; n = 5) bone marrow by flow cytometry. Methods: Clinical bone marrow samples were analyzed using CD33/CD114/CD34/CD117/CD45. CD114 density (mean fluorescence intensity) and cellular distribution were evaluated on early blasts (CD33-), late blasts (CD33+), promyelocytes, and granulocytes. Results: Normal CD114 acquisition occurred on early blasts, peaked on promyelocytes, and decreased on granulocytes. Forty percent of CD34+ blasts expressed CD114 and one-third were early blasts. In myelodysplastic syndromes, altered CD114 distribution was more informative than density changes. In CML, CD114 density was significantly decreased on early blasts and expression was essentially limited to late blasts. We observed a specific blast dysmaturation pattern in CML involving CD33, CD34, and CD114 that was 83% sensitive and 100% specific in initial diagnosis. Conclusions: CD114 provides useful additional detail in phenotypic assessment of hematopoietic precursor maturation.

AB - Objectives: To characterize granulocyte colony-stimulating factor receptor (CD114) expression in normal (n = 20), myelodysplastic (n = 34), and chronic myelogenous leukemia (CML; n = 5) bone marrow by flow cytometry. Methods: Clinical bone marrow samples were analyzed using CD33/CD114/CD34/CD117/CD45. CD114 density (mean fluorescence intensity) and cellular distribution were evaluated on early blasts (CD33-), late blasts (CD33+), promyelocytes, and granulocytes. Results: Normal CD114 acquisition occurred on early blasts, peaked on promyelocytes, and decreased on granulocytes. Forty percent of CD34+ blasts expressed CD114 and one-third were early blasts. In myelodysplastic syndromes, altered CD114 distribution was more informative than density changes. In CML, CD114 density was significantly decreased on early blasts and expression was essentially limited to late blasts. We observed a specific blast dysmaturation pattern in CML involving CD33, CD34, and CD114 that was 83% sensitive and 100% specific in initial diagnosis. Conclusions: CD114 provides useful additional detail in phenotypic assessment of hematopoietic precursor maturation.

KW - CD114

KW - Chronic myelogenous leukemia

KW - Flow cytometry

KW - GCSF-R

KW - Myelodysplastic syndrome

UR - http://www.scopus.com/inward/record.url?scp=84881256477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881256477&partnerID=8YFLogxK

U2 - 10.1309/AJCPCLHZR5KUHUBM

DO - 10.1309/AJCPCLHZR5KUHUBM

M3 - Article

C2 - 23897249

AN - SCOPUS:84881256477

VL - 140

SP - 155

EP - 164

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 2

ER -